Evidence Based Medicine on FHIR Implementation Guide, published by HL7 International / Clinical Decision Support. This guide is not an authorized publication; it is the continuous build for version 2.0.0-ballot built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/ebm/ and changes regularly. See the Directory of published versions
Active as of 2021-11-04 |
{
"resourceType" : "ActivityDefinition",
"id" : "213",
"meta" : {
"versionId" : "7",
"lastUpdated" : "2023-12-05T12:52:51.103Z",
"profile" : [
🔗 "http://hl7.org/fhir/uv/ebm/StructureDefinition/recommendation-action"
]
},
"text" : {
"status" : "extensions",
"div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p><b style=\"color: maroon\">Exception generating Narrative: Error @1, 2: Premature ExpressionNode termination at unexpected token "=="</b></p></div>"
},
"url" : "https://fevir.net/resources/ActivityDefinition/213",
"identifier" : [
{
"type" : {
"coding" : [
{
"system" : "http://terminology.hl7.org/CodeSystem/v2-0203",
"code" : "ACSN",
"display" : "Accession ID"
}
],
"text" : "FEvIR Object Identifier"
},
"system" : "https://fevir.net",
"value" : "213",
"assigner" : {
"display" : "Computable Publishing LLC"
}
},
{
"system" : "urn:ietf:rfc:3986",
"value" : "urn:oid:2.16.840.1.113883.4.642.40.44.11.1"
}
],
"version" : "2.0.0-ballot",
"name" : "IV_remdesivir_200_mg_then_100_mg_day_for_9_days",
"title" : "IV remdesivir 200 mg then 100 mg/day for 9 days",
"status" : "active",
"date" : "2021-11-04T13:34:54.626Z",
"publisher" : "HL7 International / Clinical Decision Support",
"contact" : [
{
"name" : "HL7 International / Clinical Decision Support",
"telecom" : [
{
"system" : "url",
"value" : "http://www.hl7.org/Special/committees/dss"
}
]
}
],
"description" : "This example uses the Dosage datatype to represent dosing for IV remdesivir.",
"jurisdiction" : [
{
"coding" : [
{
"system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
"code" : "001",
"display" : "World"
}
]
}
],
"copyright" : "https://creativecommons.org/licenses/by-nc-sa/4.0/",
"author" : [
{
"name" : "Brian S. Alper"
}
],
"relatedArtifact" : [
{
"type" : "cite-as",
"citation" : "IV remdesivir 200 mg then 100 mg/day for 9 days [ActivityDefinition]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 213. Revised 2021-11-04. Available at: https://fevir.net/resources/ActivityDefinition/213. Computable resource at: https://fevir.net/resources/ActivityDefinition/213."
}
],
"kind" : "MedicationRequest",
"code" : {
"coding" : [
{
"system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
"code" : "2284960",
"display" : "Remdesivir 100 mg Injection"
}
]
},
"intent" : "order",
"dosage" : [
{
"sequence" : 1,
"text" : "IV remdesivir 200 mg once on day 1",
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous use"
}
]
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 2
}
}
]
},
{
"sequence" : 2,
"text" : "IV remdesivir 100 mg once daily on days 2 through 10",
"route" : {
"coding" : [
{
"system" : "http://snomed.info/sct",
"code" : "47625008",
"display" : "Intravenous use"
}
]
},
"doseAndRate" : [
{
"doseQuantity" : {
"value" : 1
}
}
]
}
]
}